Laurion Capital Management’s Elevance Health ELV Stock Holding History

Laurion Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-91,100	Closed	-$24.5M	–	720
2020 Q3	$24.5M	Buy	91,100 +32,500	+55%	+$8.74M	0.29%	84
2020 Q2	$15.4M	Buy	+58,600	New	+$15.6M	0.17%	142
2019 Q3	–	Sell	-5,700	Closed	-$1.61M	–	1083
2019 Q2	$1.61M	Sell	5,700 -2,900	-34%	-$792K	0.02%	479
2019 Q1	$2.47M	Sell	8,600 -6,500	-43%	-$1.88M	0.03%	291
2018 Q4	$3.96M	Buy	+15,100	New	+$4.15M	0.07%	333
2015 Q3	–	Sell	-1,800,000	Closed	-$295M	–	774
2015 Q2	$295M	Buy	1,800,000 +800,000	+80%	+$128M	2.72%	4
2015 Q1	$154M	Buy	+1,000,000	New	+$142M	3%	3
2013 Q3	–	Sell	-41,300	Closed	-$3.38M	–	190
2013 Q2	$3.38M	Buy	+41,300	New	+$3.09M	0.21%	85

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Laurion Capital Management's ELV Position: Q3 2025 in Review

Laurion Capital Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,550 shares — an estimated $603K sold.

Laurion Capital Management first reported a position in ELV in Q3 2013 and held it in 19 quarters. The position peaked at $32.1M in Q1 2015. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Laurion Capital Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Laurion Capital Management sold 1,550 Elevance Health shares in Q3 2025, an estimated $603K.
Laurion Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 19 quarters.
Laurion Capital Management's Elevance Health position peaked at $32.1M in Q1 2015.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.